Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Laminin Gamma 2 (LAMC2)
B2T; EBR2; EBR2A; LAMB2T; LAMNB2; Kalinin/nicein/epiligrin 100 kDa subunit; Cell-scattering factor 140 kDa subunit; Ladsin 140 kDa; Large adhesive scatter factor 140 kDa
- Product No.SEC083Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range15.6-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 6.2pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 490
For more details, please contact local distributors! US$ 700 US$ 3150 US$ 5950 US$ 49000
Specificity
This assay has high sensitivity and excellent specificity for detection of Laminin Gamma 2 (LAMC2).
No significant cross-reactivity or interference between Laminin Gamma 2 (LAMC2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Laminin Gamma 2 (LAMC2) and the recovery rates were calculated by comparing the measured value to the expected amount of Laminin Gamma 2 (LAMC2) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 78-98 | 85 |
EDTA plasma(n=5) | 80-89 | 83 |
heparin plasma(n=5) | 96-104 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Laminin Gamma 2 (LAMC2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Laminin Gamma 2 (LAMC2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Laminin Gamma 2 (LAMC2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 82-102% | 81-104% | 94-103% | 90-98% |
EDTA plasma(n=5) | 92-99% | 81-88% | 79-99% | 91-101% |
heparin plasma(n=5) | 95-104% | 93-101% | 80-89% | 98-105% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of Kit
- ELISA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Streptavidin
- Fast blue Protein Stain solution
- Single-component Reagents of FLIA Kit
- Streptavidin-Agarose Beads
Magazine | Citations |
Molecular & Cellular Proteomics | LAMC2: A promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues Mcponline: 023507 |
Clinical Cancer Research | Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer Pubmed:25239611 |
British journal of cancer | Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer PubMed: 26180921 |
U.S. National Library of Medicine | Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer pubmed:27462170 |
American Journal of Obstetrics & Gynecology MFM | PRETERM BIRTH PREDICTION IN ASYMPTOMATIC WOMEN AT MID-GESTATION USING A PANEL OF NOVEL PROTEIN BIOMARKERS: The Prediction of PreTerm … |
Biomarkers of Preterm Birth |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPC083Hu02 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC083Hu05 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC083Hu01 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPC083Hu03 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC083Hu01 | Polyclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
PAC083Hu03 | Polyclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
PAC083Hu02 | Polyclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
MAC083Hu22 | Monoclonal Antibody to Laminin Gamma 2 (LAMC2) | WB |
MAC083Hu21 | Monoclonal Antibody to Laminin Gamma 2 (LAMC2) | WB |
SEC083Hu | ELISA Kit for Laminin Gamma 2 (LAMC2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC083Hu | Multiplex Assay Kit for Laminin Gamma 2 (LAMC2) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |